Why Xylazine Is Showing Up in California’s Drug Supply
In recent years, health officials across the United States have reported an increase in fentanyl being mixed with xylazine, a veterinary sedative sometimes referred to as “tranq.” While xylazine is not an opioid, it is increasingly found in the illicit opioid supply — including fentanyl — in multiple states.
For Californians, this matters because it changes how overdose risk looks and how symptoms may present.
- Is not approved for human use
- Does not respond to naloxone (Narcan)
- Can cause severe sedation and slowed breathing
- Has been linked to serious skin wounds in some cases
When combined with fentanyl, the risks become more complex. Fentanyl suppresses breathing. Xylazine adds sedation and can further depress the central nervous system.
This article explains what xylazine is, why it’s appearing in fentanyl, what Californians should understand about overdose risk, and what to do if you’re worried about exposure — without exaggeration or alarmism.
For authoritative information on xylazine, the National Institute on Drug Abuse (NIDA) provides updated research and public health guidance.
What Xylazine Does — and Why It’s Different From Opioids
Xylazine is a veterinary tranquilizer used to sedate large animals. It is not an opioid, and it is not approved for human use. However, it has increasingly been identified in the illicit fentanyl supply in several states.
Because xylazine is not an opioid, it behaves differently in the body.
How Xylazine Affects the Body
Xylazine is a sedative that acts on the central nervous system. In humans, exposure may cause:
- Profound sedation
- Slowed breathing
- Low blood pressure
- Decreased heart rate
- Confusion or extreme drowsiness
Unlike opioids, xylazine does not act on opioid receptors. This is important because medications like naloxone (Narcan) reverse opioid overdoses — but they do not reverse the sedative effects of xylazine.
That said, naloxone should still be administered in any suspected opioid overdose, because fentanyl may still be present and can be reversed.
What Xylazine Does — and Why It’s Different From Opioids
Xylazine is a veterinary tranquilizer used to sedate large animals. It is not an opioid, and it is not approved for human use. However, it has increasingly been identified in the illicit fentanyl supply in several states.
Because xylazine is not an opioid, it behaves differently in the body.
How Xylazine Affects the Body
Xylazine is a sedative that acts on the central nervous system. In humans, exposure may cause:
- Profound sedation
- Slowed breathing
- Low blood pressure
- Decreased heart rate
- Confusion or extreme drowsiness
Unlike opioids, xylazine does not act on opioid receptors. This is important because medications like naloxone (Narcan) reverse opioid overdoses — but they do not reverse the sedative effects of xylazine.
That said, naloxone should still be administered in any suspected opioid overdose, because fentanyl may still be present and can be reversed.
A Changing Drug Supply in California
Public health agencies, including the National Institute on Drug Abuse (NIDA), have reported that xylazine is increasingly detected in fentanyl samples in parts of the United States. While regional patterns vary, the broader trend reflects a changing and unpredictable illicit drug supply.
For Californians, this underscores an important reality:
People may not always know what substances are present.
And when the drug supply changes, overdose risk can change with it.
What Californians Should Watch For (Without Panic)
Hearing about xylazine in the fentanyl supply can sound alarming — but the goal is awareness, not fear.
Because xylazine is a sedative, exposure may look like:
- Extreme drowsiness that doesn’t improve
- Slow or shallow breathing
- Very low responsiveness
- Pale, cool, or clammy skin
- Slowed heart rate
In suspected overdoses where fentanyl may be involved, naloxone should still be administered immediately, even if xylazine is suspected. Naloxone can reverse the opioid component and restore breathing.
Emergency services should always be contacted in suspected overdose situations.
Why Wound Concerns Have Been Reported
Some public health reports have linked xylazine exposure to serious skin wounds. While the exact cause is still being studied, wounds associated with xylazine exposure may:
- Appear away from injection sites
- Be slow to heal
- Become infected if untreated
This does not mean everyone exposed will develop wounds — but it reinforces how unpredictable the drug supply has become.
A Changing Risk Landscape in California
California’s overdose patterns reflect broader national trends involving fentanyl and polysubstance exposure. For families wanting to understand local context, our breakdown of Riverside County overdose trends explains how fentanyl and mixed substances are affecting communities in the region.
The presence of xylazine reinforces one key point:
The drug supply is evolving, and unpredictability increases risk.
Awareness, access to naloxone, and early support matter more than ever.
When to Seek Help or an Assessment
If you’re worried about fentanyl exposure, possible xylazine involvement, or escalating opioid use, you don’t need to wait for a crisis.
It may be time to reach out if:
- Overdose has occurred before
- Fentanyl use is suspected
- Sedation episodes are increasing
- You’re unsure what substances may be involved
- Withdrawal attempts have been unsuccessful
Many Californians contact New Beginnings Recovery simply to talk through what’s happening and understand what medically supervised detox may involve.
A confidential admissions call can provide clarity about next steps, including medical detox options and continued care — without pressure.
When the drug supply becomes unpredictable, early assessment can make a meaningful difference in safety.